LiberoThera Co., Ltd.

Private

TokyoHealthcare & Life Scienceshttps://www.liberothera.com/

Last Round

VC Round

Aug 1, 2024

Company Overview

LiberoThera Co., Ltd. is a biotechnology company that develops novel therapeutics targeting complex membrane proteins, such as G protein-coupled receptors (GPCRs), using proprietary cell-free protein synthesis and non-canonical amino acid incorporation technologies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

GPCRG protein-coupled receptorsantibody discoverycell-free protein synthesismembrane proteinCROcontract research organizationprotein engineeringnon-canonical amino acidbiotech drug discoverytherapeutic antibodydrug discovery platformbiologicswet-lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LiberoThera Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

LiberoThera Co., Ltd. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

LiberoThera Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Aug 1, 2024
VC Round	Aug 5, 2021
VC Round	May 14, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

奥村洋一

CEO

Executive Team

LiberoThera Co., Ltd. Investors

Notable investors and investment history

LiberoThera Co., Ltd. investors
Investor	Rounds
MP Healthcare Venture Management	VC Round
Taiho Ventures	VC Round
Beyond Next Ventures	VC Round
Miyagin Venture Capital	VC Round
UTokyo Innovation Platform Co., Ltd.	VC Round

View all Investors

LiberoThera Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

LiberoThera Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LiberoThera Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo

Employee Range3

Year Founded2018

Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.